Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
NitroPep is a UK private company and University of Birmingham spinout developing antimicrobial and antiviral coating technologies for high-touch surfaces and air filtration systems. Its core technology bonds antimicrobial actives to metal and plastic surfaces to rapidly kill pathogens on contact, with published and institutional reports describing activity against organisms including MRSA, Escherichia coli, fungi, and SARS-CoV-2. The company appears to operate more as a healthcare materials and infection-prevention technology developer than as a therapeutic drug developer. NitroPep has also worked with partners on coated air filters intended for transport and built-environment applications. The business is active and privately held, with a registered office in County Durham, England.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on NitroPep.